Immunization with a tetramer derivative of an anti-inflammatory pentapeptide produced by Entamoeba histolytica protects gerbils (Meriones unguiculatus) against experimental amoebic abscess of the liver

Parasite Immunology

Volumn 26, Issue 8-9, 2004, Pages 343-349

  Giménez Scherer, Juan Antonio ^a   Cárdenas, Guadalupe ^a   López Osuna, Martha ^a   Velázquez, Juan Raymundo ^a   Rico, Guadalupe ^a   Isibasi, Armando ^b   Maldonado, Ma Del Carmen ^b   Morales, Ma Esther ^a   Fernández Diez, Jorge ^a   Kretschmer, Roberto R ^a,c  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c NONE   (Mexico)

Author keywords

Entamoeba histolytica; Gerbils; Liver abscess; Pentapeptide; Protection

Indexed keywords

ANTIINFLAMMATORY AGENT; CHEMOTACTIC PEPTIDE; FREUND ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; LYSINE; METHIONYLGLUTAMINYLCYSTEINYLASPARAGINYLSERINE; MONOCYTE LOCOMOTION INHIBITORY FACTOR; MULTIPLE ANTIGEN PEPTIDE SYSTEM; PENTAPEPTIDE; TETRAMER; UNCLASSIFIED DRUG;

AMEBIASIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENTAMOEBA HISTOLYTICA; GERBIL; IMMUNITY; IMMUNIZATION; IMMUNOSTIMULATION; IN VIVO STUDY; LISTERIA MONOCYTOGENES; LIVER ABSCESS; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ENTAMOEBA HISTOLYTICA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GERBILLINAE; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; IMMUNOGLOBULIN G; LIVER ABSCESS, AMEBIC; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; OLIGOPEPTIDES; PEPTIDES; RANDOM ALLOCATION;

EID: 13744256341     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9838.2004.00718.x     Document Type: Article

References (41)

1. Pérez-Tamayo R. Pathology of amebiasis. In Amebiasis, ed. Martínez-Palomo A. Amsterdam: Elsevier; 1986: 45-95.
2. Councilman WT & Lafleur HA. Amoebic dysentery. Johns Hopkins Hasp Rep 1891; 2: 395-548.
3. Tsutsumi V, Mena-López R, Anaya Velázquez F & Martínez-Palomo A. Cellular basis of experimental amebic liver abscess formation. Am J Path 1984; 117: 81-90.
4. Sepúlveda B & Martínez-Palomo A. Immunology of amebiasis by Entamoeba histolytica. In Immunology of Parasitic Diseases, eds Cohen S, Warren KS. Oxford: Blackwell Scientific Publications; 1982: 170-191.
5. Kretschmer RR, Collado L, Pacheco G et al. Inhibition of monocyte locomotion by products of axenically grown Entamoeba histolytica. Parasite Immunol 1985; 7: 527-543.
6. Kretschmer RR, Rico G & Giménez JA. A novel anti-inflammatory oligopeptide produced by Entamoeba histolytica. Mol Biochem Parasitol 2001; 112: 201-209.
7. Silva-García R, Rico-Rosillo G, Espinosa-Cantelano M, Giménez-Scherer JA & Kretschmer RR. Entamoeba dispar does not produce the Monocyte Locomotion Inhibitory Factor (MLIF) produced by Entamoeba histolytica. Parasite Immunol 2003; 25: 99-101.
8. Rico G, Díaz O, Giménez JA & Kretschmer RR. Effect of the Monocyte Locomotion Inhibitory Factor (MLIF) produced by Entamoeba histolytica upon the respiratory burst of human leukocytes. Arch Med Res 1992; 23: 157-159.
9. Rico G, Leandro E, Rojas S, Giménez JA & Kretschmer RR. The monocyte locomotion inhibitory factor produced by Entamoeba histolytica inhibits induced nitric oxide production in human leucocytes. Parasitol Res 2003; 90: 264-267.
10. Rico G, Arellano J & Kretschmer RR. The human monocyte locomotion inhibitory factor produced by Entamoeba histolytica does not inhibit the locomotion of human eosinophils. Parasitol Res 1998; 84: 522-523.
11. Giménez-Scherer JA, Rico G, Fernández J & Kretschmer RR. Inhibition of contact cutaneous delayed hypersensitivity reactions to DNBC in guinea pigs by the Monocyte Locomotion Inhibitory Factor (MLIF) produced by axenically grown Entamoeba histolytica. Arch Med Res 1997; 28: s237-s238.
12. Giménez-Scherer JA, Arenas E, Díaz L, Rico G, Fernández-Díez J & Kretschmer RR. Effect of Monocytes Locomotion Inhibitory Factor (MLIF) produced by Entamoeba histolytica on the expression of cell adhesion molecules (CAMs) in the skin of guinea pigs. Arch Med Res 2000; 31: s92-s93.
13. http://www.sanger.ac.uk/proyects/E_histolytica/blast_server.schtml. 2004.
14. National Center for Biotechnology Information (NCBI) www.ncbi.nlm.nih. gov/cgi-bin (blast/nph blast). 2004.
15. Utrera-Barillas D, Velázquez JR, Enciso A et al. An anti-inflammatory oligopeptide produced by Entamoeba histolytica down-regulates the expression of pro-inflammatory chemokines. Parasite Immunol 2003; 25: 475-482.
16. Kretschmer RR, Velázquez JR, Utrera-Barillas D, Zentella A & Domínguez A. The amebic anti-inflammatory Monocyte Locomotion Inhibitory Factor (MLIF) inhibits NF-κB nuclear translocation in human monocytes. FASEB J 2004, 18A, 1147.
17. Velázquez JR & Kretschmer RR. Entamoeba histolytica. A remarkable anti-inflammatory parasite. Inmunologia 2004; 23: 200-206.
18. López-Osuna M, Cárdenas G, Isario J et al. Induction of protective immunity against experimental amebic abscess of the liver (EAAL) using the Monocyte Locomotion Inhibitory Factor (MLIF) produced by Entamoeba histolytica. A preliminary Report. Arch Med Res 2000; 31: s110-s111.
19. Cárdenas-Mondragón MG. Inducción de Inmunidad Protectora contra el Absceso Hepático Amibiano Experimental en Gerbos (Meriones unguiculatus) Utilizando un Oligopéptido Anti-Inflamatorio Producido par la Entamoeba histolytica. Master's Degree Thesis. México, Instituto Politécnico Nacional. 2002.
20. Tam JP. Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci 1988; 85: 5409-5413.
21. Francis MJ. Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of. Foot-and-Mouth Dis Virus Immunol 1991; 73: 249-254.
22. Velázquez JR, Llaguno P, Fernández-Díez J et al. Antigen induced eosinophilia protects gerbils (Meriones unguiculatus) against experimental amebic abscess of the liver. Arch Med Res 1995; 26: s93-s98.
23. Academia Nacional de Medicina. In Guía para el Cuidado y Usa de los Animales de Laboratorio, Mexico: Academia Nacional de Medicina; 1999: 146.
24. Olivos-García A, Nequiz-Avendaño M, Tello E et al. Inflammation, complement, ischemia and amoebic survival in acute experimental amoebic liver abscesses in hamsters. Exp Mol Pathol 2004; 77: 66-71.
25. Palacios-Corona R, Said-Fernández S, Ortiz-Navarrete V & González-Garza MT. Desarrollo de abscesos hepáticos experimentales en ratones BALB/c en presencia de un factor inhibidor de la activación de macrófagos. Foro Nacional Invest En Salud, Cocoyoc, Morelos (México) 2001; 10: 57.
26. AOAC. Listeria species: Biochemical identification method. In Official Methods of Analysis of AOAC International, eds Cuniff PA, Gaithersburg, MD, USA: AOAC International; 1995: 94-98.
27. Huet C. Purification of immunoglobulins. In Cell Biology, A Laboratory Handbook, ed. Celis JE. New York: Academic Press; 2000: 421-426.
28. Avrameas S. Coupling of enzymes to proteins with gluteraldehyde. Immunochem 1969; 6: 43-53.
29. Towbin HT, Staelin T & Gordon J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the Natl Acad Sci (USA) 1979, 4350-4354.
30. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scan J Clin Invest 1968; 21: 77-109.
31. Moreno-Lafont MC, López-Santiago R, Paredes-Cervantes V, Estrada-Aguilera A & Santos-Argumedo L. Activation and proliferation of T lymphocyte subpopulations in patients with brucellosis. Arch Med Res 2003; 34: 184-193.
32. Kahn HA & Sempos CT. Follow-up studies: life tables. In Statistical Methods in Epidemiology and Biostatistics. New York: Oxford University Press; 1989: 168-205.
33. Colton T. Statistics in Medicine. Boston: Little Brown; 1974.
34. Kretschmer RR & López Osuna M. Effector mechanisms and immunity to amebas. In Infection and Disease by E. histolytica, ed. Kretschmer RR. Boca Raton: CRC Press; 1990: 105-122.
35. Zinkernagel RM. On natural and artificial vaccination. Ann Rev Immunol, 2003; 21: 515-546.
36. Rivero-Nava L, Aguirre-García J, Shibayama-Salas M, Hernández-Pando R, Tsusumi V & Calderón J. Entamoeba histolytica acute granulomatous intestinal lesions in normal and neutrophil-depleted mice. Exp Parasitol 2002; 101: 183-192.
37. Velázquez C, Shibayama-Salas M, Aguirre García J, Tsusumi V & Calderón J. Role of neutrophils in innate resistance to Entamoeba histolytica liver infection in mice. Parasite Immunol 1998; 20: 255-262.
38. Ferreira MB, da Silva SL & Carlos AG. Atopy and helminths. Allerg Immunol 2002; 34: 10-12.
39. Ramaswamy K, Salafsky B, Potluri S, He YX, Li JW & Shibuya T. Secretion of an anti-inflammatory, immunomodulatory factor by Schistosomulae of Schistosoma mansoni. J Inflamm 1995; 46: 13-22.
40. Day I, Keller K, Belley A & Chadee K. Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica. Proc Natl Acad Sci 2003; 100: 13561-13566.
41. Marinets A, Zhang T, Guillén N et al. Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica. J Exp Med 1997; 186: 1557-1565.